Sequenom Forms In-Network Contracts
News May 04, 2016
Sequenom, Inc. has entered into agreements with Blue Cross and Blue Shield of Georgia, Inc. (effective 4/11/16), Anthem Blue Cross and Blue Shield Health Plans for Indiana, Kentucky, Missouri, Ohio and Wisconsin (effective 5/15), and Anthem Blue Cross and Blue Shield in Virginia (effective 5/23/16).
The agreements provide in-network coverage for Sequenom Laboratories™' noninvasive prenatal tests for both high and average-risk pregnancies to Anthem's members in those states. The Georgia agreement does not include HMO plans, and the Virginia agreement does not include HealthKeepers products.
"Becoming an in-network provider with leading health insurers, particularly for average risk pregnancies, is a critical component of our commercialization plan," said Dirk van den Boom, Ph.D., President and CEO of Sequenom. "The addition of these seven states to our Anthem Blue Cross and Blue Shield relationship represents meaningful progress in our efforts to bring the benefits of noninvasive prenatal testing to women throughout the United States."
Blood Test To Determine When It Is Safe To Return To Play After A Sports-related ConcussionNews
A high-sensitive blood test can aid concussed hockey players when it might be safe to return to play. In a study published by the journal Neurology, researchers at Sahlgrenska Academy have identified a superior blood-based biomarker for assessing subtle brain injury.READ MORE
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018
16th Annual Conference on Laboratory Medicine and Pathology
Sep 17 - Sep 18, 2018